Accounting for attenuation due to a patient’s blood volume or skin colour could make Cherenkov imaging a reliable indicator of delivered radiation dose
In a new take on targeted radionuclide therapy, engineered bacteria injected into tumours attract beta-emitting radiopharmaceuticals to kill the cancer cells
Researchers are studying new ways to deliver adaptive radiotherapy by adjusting prescription doses on the day of treatment, an approach called adaptive fractionation